US equities
|
NVDA
$153.06
▼-1.54%
MU
$702.01
▼-1.46%
AMD
$511.98
▲+1.70%
SPCX
$144.85
▲+2.23%
SNDK
$771.47
▼-3.23%
TSLA
$381.07
▲+0.25%
AAPL
$353.11
▲+0.34%
AMZN
$263.86
▲+2.31%
NVDA
$153.06
▼-1.54%
MU
$702.01
▼-1.46%
AMD
$511.98
▲+1.70%
SPCX
$144.85
▲+2.23%
SNDK
$771.47
▼-3.23%
TSLA
$381.07
▲+0.25%
AAPL
$353.11
▲+0.34%
AMZN
$263.86
▲+2.31%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Tools
My watchlist
My portfolio
Recent quotes
Latest News about schedule I
Recent news which mentions schedule I
DEA Schedules Hearing On Proposed Ban Of Psychedelic Compounds With Therapeutic Potential
August 28, 2024
Tickers
DOC
NEWS
Tags
FDA
DoC
News
From
Benzinga
DEA Clears This NASDAQ-Traded 'Plant-Touching' Firm To Research And Produce Schedule I And II Plant-Based Drugs
February 23, 2024
Tickers
BGXX
DEA
Tags
schedule II
Groovy Singh
Benzinga
From
Benzinga